Prothena Corporation plc
Prothena to Present at the Jefferies 2014 Global Healthcare Conference in New York
DGAP-News: Prothena Corporation / 27.05.2014 / 22:05 --------------------------------------------------------------------- DUBLIN, Ireland, 2014-05-27 22:05 CEST (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion, announced today that Dale Schenk, PhD, the Company's President and Chief Executive Officer, will be presenting at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014, at 8:00 AM ET. The conference will be held at The Grand Hyatt New York. A live webcast of the presentation can be accessed through the investor relations section of the Company's website at www.prothena.com. Following the live presentation, a reply of the webcast will be available on the Company's website for 90 days. About Prothena Prothena Corporation plc is a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion. These potential therapies have a number of indications, including AL and AA forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002), and novel cell adhesion targets involved in inflammatory diseases and metastatic cancers (PRX003). For more information, please visit www.prothena.com. For more information, please visit the Company's web site at www.prothena.com. CONTACT: Investors: Tran Nguyen, CFO 650-837-8535, IR@prothena.com Media: Anita Kawatra 646-256-5116, anita.kawatra@prothena.com News Source: NASDAQ OMX End of Corporate News --------------------------------------------------------------------- 27.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Prothena Corporation Ireland ISIN: IE00B91XRN20 End of News DGAP News-Service --------------------------------------------------------------------- 270856 27.05.2014
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden